Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03791216 · ClinicalTrials.gov registry record
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
A clinical trial of Psoriasis, sponsored by Northwestern University.
- Completed
- Registry status
- 62
- Enrollment target
- 1
- Study location
NCT03791216 is a study of Psoriasis that has completed, run by Northwestern University. The registered enrollment target is 62 participants, below the 488-participant average among 125 other Psoriasis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03791216, a study of Psoriasis, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess differences in inflammatory proteins, lipoprotein composition, cholesterol efflux and HDL-proteome in moderate-to-severe pediatric psoriasis who at baseline begin systemically administered therapy vs: a) healthy controls; and b) patients with milder psoriasis.
Conditions Studied
Interventions
- OTHER Fasting blood draw for lipid assessments
Study Locations (1)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2025-06-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03791216
The ClinicalTrials.gov registry entry for NCT03791216 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 488-participant average among 125 other Psoriasis trials with a reported enrollment target (87% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Psoriasis appearing as the primary indexed condition, and to 1 intervention - of which Fasting blood draw for lipid assessments is the first listed.
NCT03791216 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03791216 about?
NCT03791216 is a clinical study titled "Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment". This study will assess differences in inflammatory proteins, lipoprotein composition, cholesterol efflux and HDL-proteome in moderate-to-severe pediatric psoriasis who at baseline begin systemically administered therapy vs: a) healthy controls; and b) patients with milder psoriasis.
What is the current status of trial NCT03791216?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2018-12-01. Estimated completion is 2025-06-18.
What conditions does trial NCT03791216 study?
This clinical trial studies the following conditions: Psoriasis.
What interventions are being tested in trial NCT03791216?
The interventions under investigation include: Fasting blood draw for lipid assessments (OTHER).
Who is sponsoring clinical trial NCT03791216?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03791216 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
RECRUITING · NA
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
Duobrii in Combination With Biologics
RECRUITING · Phase 4
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.